Skip to main content

Agios Pharmaceuticals, Inc.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Agios Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
1 insider, $1.06M in total
Insiders trading
1
Net value
−$1.06M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Agios Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Agios Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Gheuens SarahChief Medical Officer54,645Aug 6, 20269
Backstrom Jay T.Director1,447Jul 10, 20262
Capello Jeffrey DDirector10,865Jun 23, 20262
Foster-Cheek Kaye IDirector10,284Jun 23, 20261
Fouse Jacqualyn ADirector154,156Jun 23, 20261
Goff BrianChief Executive Officer184,508Jun 23, 20264
Smith CynthiaDirector15,230Jun 23, 20261
Ho MaykinDirector19,848Jun 23, 20261
Scadden DavidDirector20,419Jun 23, 20264
Ballal Rahul D.Director15,230Jun 23, 20261
Owen Catherine E.Director10,865Jun 23, 20262
Jones CeciliaChief Financial Officer54,998Jun 23, 20265
Burns James WilliamChief Legal Officer49,306Jun 23, 20264
Milanova TsvetaChief Commercial Officer46,829Jun 23, 20265
Viswanadhan KrishnanChief Strategy and Operations10,282Jun 23, 20264
Washburn Theodore James Jr.Principal Accounting Officer868Mar 5, 20262
Schenkein David PDirector126,242Jun 24, 20240
Poddar RichaChief Commercial Officer8,508Oct 18, 20220
Maraganore JohnDirector30,028Jun 23, 20220
Clancy Paul JDirector6,549Jun 23, 20220
Clark Ian TDirector6,549May 24, 20220
Biller JonathanChief Financial Officer22,953Mar 3, 20220
Car BruceChief Scientific Officer16,752Mar 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 16, 2022 (view filing)Feb 142 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−504$31.25−$15.8K−15.3%2.78K after
Feb 18, 2022 (view filing)Feb 162 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−233$30.81−$7.18K−8.4%2.55K after
Mar 1, 2022 (view filing)Feb 254 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−108$30.00−$3.24K−4.1%2.55K after
Jan 19, 2023 (view filing)Jan 172 daysSchenkein David PDirectorSSale−20.0K$28.85−$577.1K−14.5%117.9K after2 lots
Feb 1, 2023 (view filing)Jan 302 daysSchenkein David PDirectorSSale−20.0K$29.33−$586.6K−14.5%117.9K after2 lots
Feb 15, 2023 (view filing)Feb 132 daysSchenkein David PDirectorSSale−20.0K$28.62−$572.4K−14.5%117.9K after
Feb 16, 2023 (view filing)Feb 142 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−504$28.59−$14.4K−14.8%2.90K after
Feb 21, 2023 (view filing)Feb 165 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−233$27.21−$6.34K−8.0%2.67K after
Mar 1, 2023 (view filing)Feb 272 daysSchenkein David PDirectorSSale−20.0K$25.37−$507.4K−14.5%117.9K after
Mar 7, 2023 (view filing)Mar 34 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−504$24.29−$12.2K−15.5%2.74K after
Mar 15, 2023 (view filing)Mar 132 daysSchenkein David PDirectorSSale−20.0K$22.49−$449.8K−14.5%117.9K after2 lots
Mar 29, 2023 (view filing)Mar 272 daysSchenkein David PDirectorSSale−20.0K$22.15−$443.0K−14.5%117.9K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysSchenkein David PDirectorSSale−16.4K$22.85−$373.9K−12.2%117.9K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayMilanova TsvetaChief Commercial OfficerSSale−1.62K$28.36−$45.9K−29.7%3.83K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayJones CeciliaChief Financial OfficerSSale−1.60K$28.36−$45.3K−29.7%3.78K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayGoff BrianChief Executive OfficerSSale−11.4K$28.36−$324.7K−44.8%14.1K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayGheuens SarahChief Medical OfficerSSale−1.71K$28.36−$48.4K−6.6%24.2K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayFouse Jacqualyn ADirectorSSale−10.7K$28.36−$304.0K−9.1%107.0K after10b5-1
Jun 30, 2023 (view filing)Jun 30Same dayBurns James WilliamChief Legal OfficerSSale−1.71K$28.36−$48.4K−5.3%30.3K after10b5-1
Aug 2, 2023 (view filing)Aug 11 dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−1.23K$26.26−$32.4K−17.9%5.66K after10b5-1
Aug 9, 2023 (view filing)Aug 72 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−2.92K$25.39−$74.1K−51.6%2.74K after
Aug 10, 2023 (view filing)Aug 82 daysGoff BrianChief Executive OfficerSSale−10.2K$25.48−$259.3K−27.7%26.6K after10b5-1
Aug 11, 2023 (view filing)Aug 92 daysFoster-Cheek Kaye IDirectorSSale−25.0K$25.96−$649.0K−68.4%11.5K after
Aug 21, 2023 (view filing)Aug 174 daysBurns James WilliamChief Legal OfficerSSale−6.39K$26.28−$168.1K−21.1%23.9K after
Sep 28, 2023 (view filing)Sep 28Same dayJones CeciliaChief Financial OfficerSSale−2.18K$24.79−$54.0K−18.5%9.57K after10b5-1
Jan 5, 2024 (view filing)Jan 5Same dayMilanova TsvetaChief Commercial OfficerSSale−2.90K$22.32−$64.8K−23.6%9.40K after10b5-1
Jan 9, 2024 (view filing)Jan 9Same dayGheuens SarahChief Medical OfficerSSale−1.79K$22.99−$41.1K−6.0%27.9K after10b5-1
Jan 9, 2024 (view filing)Jan 9Same dayBurns James WilliamChief Legal OfficerSSale−1.16K$22.99−$26.7K−4.2%26.3K after10b5-1
Jan 9, 2024 (view filing)Jan 9Same dayFouse Jacqualyn ADirectorSSale−8.39K$22.99−$192.9K−6.7%116.1K after10b5-1
Jan 9, 2024 (view filing)Jan 9Same dayGoff BrianChief Executive OfficerSSale−12.1K$22.99−$277.4K−23.2%40.1K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayMilanova TsvetaChief Commercial OfficerSSale−1.62K$21.64−$35.0K−10.9%13.2K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayGoff BrianChief Executive OfficerSSale−7.63K$21.64−$165.2K−13.4%49.4K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayFouse Jacqualyn ADirectorSSale−10.7K$21.64−$232.0K−7.7%129.3K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayJones CeciliaChief Financial OfficerSSale−1.89K$21.64−$40.8K−12.6%13.1K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayGheuens SarahChief Medical OfficerSSale−1.71K$21.64−$37.0K−5.1%31.9K after10b5-1
Jan 24, 2024 (view filing)Jan 24Same dayBurns James WilliamChief Legal OfficerSSale−1.71K$21.64−$37.0K−5.3%30.4K after10b5-1
Feb 14, 2024 (view filing)Feb 14Same dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−273$25.14−$6.86K−7.8%3.25K after10b5-1
Feb 14, 2024 (view filing)Feb 14Same dayBurns James WilliamChief Legal OfficerSSale−545$25.14−$13.7K−1.7%31.7K after10b5-1
Feb 14, 2024 (view filing)Feb 14Same dayGheuens SarahChief Medical OfficerSSale−642$25.14−$16.1K−1.9%33.4K after10b5-1
Feb 22, 2024 (view filing)Feb 202 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−504$26.63−$13.4K−15.5%2.74K after
Feb 27, 2024 (view filing)Feb 23-264 daysSchenkein David PDirectorSSale−68.1K$33.09−$2.25M−35.7%122.9K after2 lots
Feb 29, 2024 (view filing)Feb 272 daysSchenkein David PDirectorSSale−69.3K$34.67−$2.40M−36.1%122.9K after2 lots
Mar 5, 2024 (view filing)Mar 5Same dayBurns James WilliamChief Legal OfficerSSale−2.64K$32.57−$86.0K−6.6%37.2K after2 lots10b5-1
Mar 5, 2024 (view filing)Mar 5Same dayGoff BrianChief Executive OfficerSSale−4.16K$32.57−$135.4K−7.2%53.8K after10b5-1
Mar 5, 2024 (view filing)Mar 5Same dayWashburn Theodore James Jr.Principal Accounting OfficerSSale−1.21K$32.57−$39.5K−20.2%4.80K after2 lots10b5-1
Mar 5, 2024 (view filing)Mar 5Same dayJones CeciliaChief Financial OfficerSSale−672$32.57−$21.9K−4.3%14.8K after10b5-1
Mar 5, 2024 (view filing)Mar 5Same dayGheuens SarahChief Medical OfficerSSale−2.64K$32.57−$86.0K−6.3%39.1K after2 lots10b5-1
Mar 7, 2024 (view filing)Mar 52 daysWashburn Theodore James Jr.Principal Accounting OfficerSSale−1.91K$31.75−$60.7K−39.9%2.89K after
Mar 7, 2024 (view filing)Mar 5-62 daysFoster-Cheek Kaye IDirectorSSale−4.71K$32.00−$150.9K−40.9%6.81K after2 lots
Mar 11, 2024 (view filing)Mar 74 daysFoster-Cheek Kaye IDirectorSSale−1.28K$31.62−$40.6K−18.9%5.52K after